Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2017
Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counsellingY Jourdy, N Chatron, M Fretigny, et al.Molecular and Cellular Biology|January 11, 2000
Sequential regulation of the small GTPase Rap1 in human plateletsB Franke, M van Triest, K M de Bruijn, et al.Pathophysiology of Haemostasis and Thrombosis|July 11, 2003
Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assayP L Turecek, K Váradi, B Keil, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|February 25, 2017
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trialsA Tiede, F Abdul-Karim, M Carcao, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|October 28, 2016
The association of haemophilic arthropathy with Health-Related Quality of Life: a post hoc analysisK Fischer, P de Kleijn, C Negrier, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medicationsD Magli-Barioz, N Ounnoughène, P Paugy, et al.Seminars in Hematology|April 9, 2004
Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UKB M Ewenstein, P Collins, M D Tarantino, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcomeK Fischer, J G van der Bom, P Molho, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|January 6, 2016
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014Y Dargaud, A Pavlova, S Lacroix-Desmazes, et al.Journal of Thrombosis and Haemostasis : JTH|April 15, 2011
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)A Tiede, U Friedrich, C Stenmo, et al.Pageof 8